Wenjin Liu

Wenjin Liu

Auto-generated profile, based on publicly available information

Wenjin Liu

Department of Nephrology, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in IEEE Transactions on Knowledge and Data Engineering
Verified
Journal Article
Closed access
GSGen Shi
Gen Shi
Yifan ZhuYifan Zhu
Yifan Zhu
WLWenjin Liu
Wenjin Liu
QYQuanming Yao
Quanming Yao
XLXuesong Li
Xuesong Li
Graph neural networks (GNNs) provide powerful insights into brain neuroimaging technology from the view of graphical networks. However, most existing GNN-based models treat the brain connectome, derived from neuroimaging, as a homogeneous graph characterized by uniform node and edge types. In fact, emerging studies have reported and emphasized the significance of heterogeneity among human brain activities, especially between the two cerebral hemispheres. Thus, homogeneous-structured brain network-based graph methods are insufficient for modeling complicated cerebral activity states. To overcome this problem, we introduce a novel heterogeneous graph neural network (HeBrainGNN) for multimodal brain neuroimaging fusion learning. HeBrainGNN first conceptualizes the brain network as a heterogeneous graph with multiple types of nodes (representing the left and right hemispheres) and edges (categorizing intra- and interhemispheric interactions). We further develop a self-supervised pretraining strategy for this heterogeneous network to address the potential overfitting problem caused by the conflict between a large parameter size and a small medical data sample size. Empirical results show the superiority of the proposed model over other existing methods in brain-related disease prediction tasks. Ablation experiments show that our heterogeneous graph-based model attaches more importance to hemispheric connections that may be neglected due to their low strength by previous homogeneous graph models. Additional experiments reveal that our pretraining strategy not only addresses the challenge of limited labeled data but also significantly enhances accuracy, affirming the potential of our approach in advancing neuroimaging analysis.

14 September 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
WLWenjin Liu
Wenjin Liu
XHXiaoqin Huang
Xiaoqin Huang
XLXuebing Liu
Xuebing Liu
DODakota Ortega
Dakota Ortega
LCLi Chen
Li Chen
JYJunwei Yang
Junwei Yang

25 January 2018 in The Journal of Clinical Hypertension
Verified
Journal Article
Closed access
LWLulu Wang
Lulu Wang
MZMingming Zhao
Mingming Zhao
WLWenjin Liu
Wenjin Liu
XLXiurong Li
Xiurong Li
HCHong Chu
Hong Chu
JYJunwei Yang
Junwei Yang

30 August 2019 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
WLWenjin Liu
Wenjin Liu
LWLulu Wang
Lulu Wang
XHXiaoqin Huang
Xiaoqin Huang
WHWeichun He
Weichun He
ZSZongwei Song
Zongwei Song
JYJunwei Yang
Junwei Yang
Impaired orthostatic blood pressure (BP) stabilization is prevalent in patients with chronic kidney disease (CKD) and is associated with adverse outcomes. We aimed to test the hypothesis that reduced hemoglobin is an important contributor to orthostatic intolerance in CKD in the present study. This study included 262 patients with non‐dialysis‐dependent CKD. Seated and standing BP was measured, and orthostatic BP reduction was calculated for both systolic BP (∆ SBP) and diastolic BP (∆ DBP). The association between orthostatic BP reduction and hemoglobin was determined by multiple linear regression models. We also performed mediation analysis to test to what extent the effect of renal dysfunction on impaired orthostatic BP stabilization can be explained by reduced hemoglobin. The mean age of the patients was 57.7 (±14.5) years, and 61.5% were male. Both ∆ SBP and ∆ DBP correlated negatively with estimated glomerular filtration rate (eGFR). With adjustment for age and sex, hemoglobin level was negatively associated with ∆ SBP (β = −1.4, SE = 0.4, P < .001) and ∆ DBP (β = −0.6, SE = 0.2, P = .009). The associations remained significant with further adjustment for additional covariates. When eGFR was introduced as a covariate, it did not eliminate the significance (both P < .05). The associations remained essentially unchanged in a sensitivity analysis excluding those with concurrent erythropoietin use. Mediation analysis demonstrated that reduced hemoglobin accounted for 35.4% (P = .004) of the effect of eGFR on ∆ SBP and 47.7% (P = .032) on ∆ DBP. Our study suggests that reduced hemoglobin is a potentially important contributor to the development of orthostatic hypotension in CKD.

10 May 2017 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
WLWenjin Liu
Wenjin Liu
LJLei Jiang
Lei Jiang
JCJianping Chen
Jianping Chen
CGChaoqing Gao
Chaoqing Gao
JZJianmei Zhou
Jianmei Zhou
JYJunwei Yang
Junwei Yang
Adipokines are a set of cytokines secreted by white adipose tissue that have been suggested to be involved in the development of cardiovascular diseases. We aimed to evaluate the cross-sectional associations of a panel of representative adipokines with cardiovascular measures in a cohort of hemodialysis patients. We measured plasma adiponectin, resistin, plasminogen activator inhibitor-1 (PAI-1), leptin, monocyte chemotactic protein 1 (MCP-1) and adipsin levels in 366 dialysis patients and 60 healthy controls. The associations of these adipokines with systolic blood pressure (assessed by ambulatory blood pressure monitoring), pulse wave velocity (PWV) and cardiac markers (BNP, NT-proBNP, Troponin I, Troponin T) in these patients were determined by general linear models with stepwise adjustment for covariates. In unadjusted comparison with controls, dialysis patients showed increased adiponectin, resistin, MCP-1 and adipsin levels, decreased PAI-1 concentrations (all p <0.001) and similar leptin levels (p = 0.82). On adjustment for body mass index and diabetes, however, the PAI-1 level was comparable between group (p = 0.06), whereas leptin levels became significantly higher in the patients(p <0.001). Higher adiponectin, lower PAI-1 and leptin levels were associated with higher systolic blood pressure, even after extensive adjustment (all p ≤ 0.01). Adiponectin was also consistently and inversely associated with PWV in fully adjusted models (p = 0.003). Resistin, PAI-1, leptin and adipsin showed negative associations with one or more circulating cardiac markers (all p ≤ 0.02). We found significant associations between adipokines and cardiovascular measures. Our data suggest the possible involvement of adipokines in cardiovascular modulation in dialysis patients.

1 March 2025 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
NSNisha Sharma
Nisha Sharma
WLWenjin Liu
Wenjin Liu
XTXiao-Qing E. Tsai
Xiao-Qing E. Tsai
ZWZhou Wang
Zhou Wang
COConnor Outtrim
Connor Outtrim
YHYufeng Huang
Yufeng Huang
Whether combining an sGC activator with an SGLT2 inhibitor could better control diabetes-associated oxidative stress and NO-cGMP signal deficiency has not yet been explored. Using the type 2 diabetic db/db mouse model, this study underscores the sGC activator avenciguat as a novel therapy for diabetic nephropathy and liver injury beyond sGLT2 inhibitors. It also highlights the need for further investigation into the combined effects of these two treatments in managing diabetic complications.